期刊文献+

9例血栓性血小板减少性紫癜的临床分析 被引量:3

The Clinic Analysis of 9 Patients of Thrombotic Thrombocytopenic Purpura
下载PDF
导出
摘要 目的分析血栓性血小板减少性紫癜(TTP)的临床特征和治疗方法选择的价值。方法对9例TTP患者的临床资料进行分析。结果9例患者6例为女性,男∶女=1∶3;其中系统性的红斑狼疮5例,严重感染、败血症3例,尿毒症1例。临床表现以血小板减少性出血、微血管病性溶血性贫血和神经系统症状的"三联症"起病的5例;三联症伴发热和肾脏病变"五联症"起病的2例;三联症伴发热起病2例。4例及时进行血浆置换为主治疗后均有效;其余5例未给予血浆置换的3例死亡。结论TTP多见于年轻女性,病因以系统性红斑狼疮最多见,感染次之。临床表现以三联征表现最多,以后多表现为四联征或五联征。及时给予血浆置换为主的治疗抢救成功率较高。 Objecttive To analyze the value of clinical feature and selective of therapy method in patients with thrombotic thrombocytopenic purpura. Methods The clinical data of 9 patients with thrombotic thrombocytopenic purpura was analyzed. Results There were 6 female in 9 patients thrombotic thrombocyto- penic purpura, and man/women was 1:3. The 5 patients were caused by SLE, and 3 were caused by serious infection, and 1 was caused by uremia. The 5 patients onsted with trilogy of plate-reduction hemorrhage. Microangiopathies hemolytic anemia and nervous system symptom, another 2 patients onsted with pentalogy of trilogy and fever, renal lesions. The 4 patients treated with plasmapheresis in time had good effect, but 3 patients were died of other 5 patients without treated with plasmapheresis. Conclusion There are more female patients in patients with thrombotic thrombocytopenic purpura. The main etiological factor is SLE, and the next in order is infection. The initial clinical manifestation is trilogy, afterward is tetrad or pentalogy. The rescue achievement ratio is higher when treated by plasmapheresis in time.
出处 《血栓与止血学》 2008年第3期126-127,共2页 Chinese Journal of Thrombosis and Hemostasis
关键词 血栓性血小板减少性紫癜 临床 治疗 Thrombotic thrombocytopenic purpura Clinic Treatment
  • 相关文献

参考文献8

二级参考文献22

  • 1袁毓贤,侯平.血栓性血小板减少性紫癜的典型与非典型临床表现[J].内科急危重症杂志,1996,2(3):127-128. 被引量:5
  • 2[1]CEOGE J,RIZUI M.Thrombotic thrombocytopenic pupura-hemolytic uremic syndrome in:Beutler E.et al.Willams Hematology 6th ed New York:Mc-Graw-Hill Book Comp[M].2001,1504-1511.
  • 3[2]KEITH R,MCCRAE,CINES D.Thrombotic thrombooytopenic and the hemolytic uremic syndrome.In:Hoffman R,et al.Hameatology basic priciply and practise 3rd ed [M].北京:科学出版社,2001,2126-2138.
  • 4[3]MARTTNEZ J.Microangiopathic hemolytic in:Beutler E.et al.Williams Hematology.6th ed New York:Mc-Graw-Hill Book Comp[M].2001,632-625.
  • 5[4]HOSLER GA,CUSUMANO AM,HUTCHINS GM.Thrombotic thrombocytopenic purpura and hemolytic uremic sydrome are distinct pathologic entitese,A revgiew of 56 antopsy cases [J].Arch Patol Lab Med,2003,127 (7) :834-839.
  • 6[5]VESELY SK,GEORGE JN,LAMMLE B,et al.ADAMT 13 activity in thrombotic thrombocytopenic purpura hemolytic uremic syndrome:relation to presenting features and clinical outcomes in a prospective cohort of 142 patients[J].Blood,2003,102(10) :60-68.
  • 7[6]ALLFOR SL,HUNT BJ,ROSEP.Guidelings diagnosis and mamanagement of thrombotic microagiopahtic haemalytic anemias [J].Br J Hemtal,2003,120(4) :556-573.
  • 8[7]MCMINN JR Jr,THOMAS IA,IERREL DR,et al.Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome a study of 78 additional patients [J].Transfusion,2003,43(3) :415-416.
  • 9[8]ARAI S,ALLAN C,STRIFF M,et al.von Willebrand factor-cleaving protease activity and protelysis of vonWillebrand factor in bone marrow trasplant associated thrombotic microgiopathy [J].Hematol J,2001,2(50) :292-299.
  • 10张之南主编.血液病诊断及疗效标准.天津:天津科学出版社,1991.245.

共引文献16

同被引文献19

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部